GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
2.1k
c/insurancefights·posted 7 months ago by u/valeria_grimaldi

three years of denial threads, summarised so you do not have to read them

Discussion Well Actually ×4 Slow Clap ×2

three years of denial threads, summarised so you do not have to read them. It is the sort of thing everyone half-believes and nobody writes down.

Asked for the policy bulletin by number and wrote the appeal against its criteria line by line. Approved on the second level after a flat first-level denial.

Spent six weeks arguing in general terms and got nowhere. Two paragraphs quoting their own criteria turned it around in eleven days.

Kept a log with every date, name of department and reference number. When they claimed no record of a call, I had the reference.

That is everything I have. The rest is opinion and I have tried to keep it out.

2,190 up / 129 down94% upvoted43 commentsid be0z3a10 Dec 2025

43 comments

16 in this archive, depth 3

best — the order this archive was captured in

u/step_therapy_sMOD207 points·7 months ago

Member and policy numbers redacted from the screenshot above. Everything else left as posted.

replysharereportpermalink
u/valeria_grimaldiOP113 points·7 months ago

ask for the clinical policy bulletin by number

replysharereportpermalink
u/peak_area_peteanalytical-29 points·7 months ago

A peer-to-peer conversation puts the prescribing clinician in front of a reviewing clinician. It bypasses the correspondence cycle entirely and is often the fastest available route.

replysharereportpermalink
u/arne_amankwah1 point·7 months ago

the denial letter names the criterion, start there

replysharereportpermalink
[removed]1 point·7 months ago

[removed by moderator]

replysharereportpermalink
u/kian_balogun1 point·7 months ago

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

replysharereportpermalink
u/line_petrov1 point·7 months ago

Is this a prior authorisation denial or a formulary exclusion?

replysharereportpermalink
u/marta_dziedzic107 points·7 months ago

Same view. The second-level appeal is where mine turned, after a first-level denial that looked final.

replysharereportpermalink
u/edit_for_clarity55 points·7 months ago

Careful — the deadline runs from the date on the letter. Waiting for a call back can cost you the appeal entirely.

replysharereportpermalink
u/marta_dziedzic35 points·7 months ago

I would not skip the peer-to-peer. It is often the fastest route and it costs a phone call.

replysharereportpermalink
u/adaeze_weiss29 points·7 months ago·edited

That criterion is from the previous plan year. The current bulletin has different wording.

replysharereportpermalink
u/marisol_moreau12 points·7 months ago

External review was the thing that finally worked. I did not know it existed until a thread on this board.

replysharereportpermalink
u/gustav_vermeulen36 points·7 months ago

deadlines run from the letter date, not from when you opened it

replysharereportpermalink
u/sofia_ferreira66 points·7 months ago

Push back: your plan is an employer plan, which changes both the appeal path and who the regulator is.

replysharereportpermalink
u/coring_the_stopper40 points·7 months ago

Why step therapy denials feel unfair and are nonetheless beatable.

The requirement is that documented trials of preferred alternatives exist. It is a record-keeping standard, not a clinical judgement about you, which is why arguing the clinical merits rarely moves it and producing dates and durations often does.

What to assemble: what was tried, at what dose, for how long, and what the documented outcome was. A one-page table with dates beats three pages of prose every time. Where a trial is contraindicated rather than simply unsuccessful, that needs to be stated explicitly by the prescriber in those terms.

None of this is legal or medical advice — it is what the threads here have found works.

replysharereportpermalink
u/adaeze_cabrera31 points·7 months ago

That advice is jurisdiction-specific and this board spans several. Say where you are.

replysharereportpermalink
Permalinked branches
Deep branches get their own page so a single reply chain can be linked and read on its own.
About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.